(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ONCOMENOPAUSE CONSORTIUM

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ONCOMENOPAUSE CONSORTIUM

ST13

US500000099451328

Class

41

Filing

99451328

Registration

8329293

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

18

Latest update

06/30/2026

Trademark type

Word

Nice classes

41

Filing date

10/20/2025

Registration date

06/30/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/30/2026

Last transaction

06/30/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Supplemental Register

Filing basis

Intent to use

First use anywhere

11/01/2025

First use in commerce

11/01/2025

Drawing code

4

Owner type

54

Owner location

CINCINNATI, OH, US

Examiner

MARTIN, LIEF ANDREW

Law office

M30

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

HERmedicine

Representatives

Yael Spiewak EPSTEIN BECKER & GREEN, P.C.

Technical classification

Nice Classes

Class 41

Vienna Codes

No Vienna codes available.

Goods and services

Class 41

Educational servicesproviding virtual educationseminarsworkshopslectureseducational materials in the fields of menopause and midlife health care for cancer survivors

Publications

History of USPTO decisions and trademark events.

18 publications found

NRCS

NOTICE OF REGISTRATION CONFIRMATION EMAILED

06/30/2026

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

06/30/2026

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

06/04/2026

IUAA

USE AMENDMENT ACCEPTED

06/02/2026

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/18/2026

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/18/2026

ALIE

ASSIGNED TO LIE

05/18/2026

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/14/2026

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

05/13/2026

IUAF

USE AMENDMENT FILED

05/13/2026

EAAU

TEAS AMENDMENT OF USE RECEIVED

05/13/2026

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/10/2026

GNRT

NON-FINAL ACTION E-MAILED

03/10/2026

CNRT

NON-FINAL ACTION WRITTEN

03/10/2026

DOCK

ASSIGNED TO EXAMINER

03/06/2026

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/11/2026

MAFR

APPLICATION FILING RECEIPT MAILED

10/20/2025

NWAP

NEW APPLICATION ENTERED

10/20/2025

Continuous trademark protection

Get notified about every new filing that threatens ONCOMENOPAUSE CONSORTIUM or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.